AgeX Therapeutics, Inc. - stock earnings
AGE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -5.4 million USD | 46000 USD |
| 2023Q2 | -2.7 million USD | 9000 USD |
| 2023Q1 | -5.5 million USD | 10000 USD |
| 2022Q4 | -2.7 million USD | 8000 USD |
| 2022Q3 | -3.3 million USD | 9000 USD |
| 2022Q2 | -3.6 million USD | 12000 USD |
| 2022Q1 | -3.4 million USD | 5000 USD |
| 2021Q4 | -2.2 million USD | 27000 USD |
| 2021Q3 | -2.0 million USD | 24000 USD |
| 2021Q2 | -2.5 million USD | 37000 USD |
| 2021Q1 | -2.1 million USD | 56000 USD |
| 2020Q4 | -2.4 million USD | 505000 USD |
| 2020Q3 | -2.5 million USD | 434000 USD |
| 2020Q2 | -2.7 million USD | 414000 USD |
| 2020Q1 | -3.2 million USD | 515000 USD |
| 2019Q4 | -2.7 million USD | 549000 USD |
| 2019Q3 | -3.2 million USD | 411000 USD |
| 2019Q2 | -3.1 million USD | 380000 USD |
| 2019Q1 | -3.2 million USD | 313000 USD |
| 2018Q4 | -3.2 million USD | 313000 USD |
| 2018Q3 | -2.2 million USD | 380000 USD |
| 2018Q2 | -1.9 million USD | 464000 USD |
| 2018Q1 | -235000 USD | 239000 USD |
| 2017Q4 | -4.6 million USD | 458000 USD |
| 2017Q3 | -2.0 million USD | 377000 USD |
| 2017Q2 | ? USD | 302000 USD |
| 2017Q1 | ? USD | 267000 USD |
| 2016Q4 | -15.5 million USD | 1.7 million USD |
AGE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -14.1 million USD | 73000 USD |
| 2022 | -10.7 million USD | 34000 USD |
| 2021 | -10.2 million USD | 144000 USD |
| 2020 | -11.0 million USD | 1.9 million USD |
| 2019 | -12.4 million USD | 1.7 million USD |
| 2018 | -7.5 million USD | 1.4 million USD |
| 2017 | -6.6 million USD | 1.4 million USD |
| 2016 | -15.5 million USD | 1.7 million USD |
AGE
Price: $11.10
52 week price:
Earnings Per Share: -0.38 USD
P/E Ratio: -1.02
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 785
Market Capitalization: 33.2 million